Back to Search

Journal article

Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: The CAP randomized clinical trial

Abstract:: Importance Prostate cancer screening remains controversial because potential mortality or quality-of-life benefits may be outweighed by harms from overdetection and overtreatment. Objective To evaluate the effect of a single prostate-specific antigen (PSA) screening intervention and standardized diagnostic pathway on prostate cancer–specific mortality. Design, Setting, and Participants The Cluster Randomized Trial of PSA Testing for Prostate Cancer (CAP) included 419 582 men aged 50 to 6...
Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Martin, R. M., Donovan, J. L., Turner, E. L., Metcalfe, C., Young, G. J., Walsh, E. I., Lane, J. A., Noble, S., Oliver, S. E., Evans, S., Sterne, J. A. C., Holding, P., Ben-Shlomo, Y., Brindle, P., Williams, N. J., Hill, E. M., Ng, S. Y., Toole, J., Tazewell, M. K., … Group, C. A. P. T. (2018). Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: The CAP randomized clinical trial. Journal of the American Medical Association, 319(9), 883–895.

MLA Style

Martin, R. M., et al. “Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial.” Journal of the American Medical Association, vol. 319, no. 9, American Medical Association , 2018, pp. 883–95.

Chicago Style

Martin, RM, JL Donovan, EL Turner, C Metcalfe, GJ Young, EI Walsh, JA Lane, et al. 2018. “Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial.” Journal of the American Medical Association 319 (9): 883–95.
Tweet
Print

Access Document

Publisher copy:: 10.1001/jama.2018.0154

Authors

+ Martin, RM More by this author

Role:

Author

ORCID:

0000-0002-7992-7719

+ Donovan, JL More by this author

Role:

Author

+ Turner, EL More by this author

Role:

Author

ORCID:

0000-0003-2575-387X

+ Metcalfe, C More by this author

Role:

Author

ORCID:

0000-0001-8318-8907

+ Young, GJ More by this author

Role:

Author

More authors...

Funding

+ National Institute for Health Research More from this funder

Grant:

NF-SI-0513-10121

Department of Health More from this funder

Bibliographic Details

Publisher:: American Medical Association Publisher's website
Journal:: Journal of the American Medical Association Journal website
Volume:: 319
Issue:: 9
Pages:: 883-895
Publication date:: 2018-03-06
Acceptance date:: 2018-01-17
DOI:: 10.1001/jama.2018.0154
EISSN:: 1538-3598
ISSN:: 0098-7484
Pmid:: 29509864

Item Description

Language:: English
Keywords:: FFR
Pubs id:: 828768
Local pid:: pubs:828768
Deposit date:: 2020-06-10

Terms of use

Copyright holder:: American Medical Association
Copyright date:: 2018
Rights statement:: © 2018 American Medical Association. All rights reserved.

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Metrics

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP